We manufacture a wide range of peptide-based generic APIs (Active Pharmaceutical Ingredients) at a commercial scale used in different applications for the human and veterinary markets. We have an extensive experience of developing robust processes and manufacturing complex generic peptides ensuring a successful track record of multiple approved and commercialized APIs globally.
Our GMP manufacturing facilities operate on stringent quality systems ensuring global compliance to the requirements of health authorities across the world including but not limited to the United States, European Union and Japan. All our generic products are accompanied by the required regulatory documentation including Drug Master Files (DMFs) , Certificate of Suitability (CEPs), as applicable.
APIs from our generic portfolio cover a vast range of applications including treatments for:
- Type 2 Diabetes
- Breast cancer
- Prostate cancer
- Autoimmune diseases
- Premature labor
- Prevention of uterine atony
- Dental infiltration
- Hypotension and more
USA, India, Belgium and Sweden
Reach out to our Generic Sales Team Generics.Sales@polypeptide.com for the latest offering.
Alternately, please use the form below for your specific request.
Send inquiry / Ask for a quote
Get contacted by one of our sales representatives
Team Generics – your key contacts